<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Heart Fail</journal-id><journal-id journal-id-type="iso-abbrev">Eur. J. Heart Fail</journal-id><journal-id journal-id-type="publisher-id">eurjhf</journal-id><journal-id journal-id-type="hwp">eurjhf</journal-id><journal-title-group><journal-title>European Journal of Heart Failure</journal-title></journal-title-group><issn pub-type="ppub">1388-9842</issn><issn pub-type="epub">1879-0844</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23329651</article-id><article-id pub-id-type="pmc">3576902</article-id><article-id pub-id-type="doi">10.1093/eurjhf/hfs204</article-id><article-id pub-id-type="publisher-id">hfs204</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Trials</subject></subj-group></article-categories><title-group><article-title>Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McMurray</surname><given-names>John J.V.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Anand</surname><given-names>Inder S.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Diaz</surname><given-names>Rafael</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Maggioni</surname><given-names>Aldo P.</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>O'Connor</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Pfeffer</surname><given-names>Marc A.</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Solomon</surname><given-names>Scott D.</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Tendera</surname><given-names>Michal</given-names></name><xref ref-type="aff" rid="af7">7</xref></contrib><contrib contrib-type="author"><name><surname>van Veldhuisen</surname><given-names>Dirk J.</given-names></name><xref ref-type="aff" rid="af8">8</xref></contrib><contrib contrib-type="author"><name><surname>Albizem</surname><given-names>Moetaz</given-names></name><xref ref-type="aff" rid="af9">9</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Sunfa</given-names></name><xref ref-type="aff" rid="af9">9</xref></contrib><contrib contrib-type="author"><name><surname>Scarlata</surname><given-names>Debra</given-names></name><xref ref-type="aff" rid="af9">9</xref></contrib><contrib contrib-type="author"><name><surname>Swedberg</surname><given-names>Karl</given-names></name><xref ref-type="aff" rid="af10">10</xref></contrib><contrib contrib-type="author"><name><surname>Young</surname><given-names>James B.</given-names></name><xref ref-type="aff" rid="af11">11</xref></contrib><contrib contrib-type="author"><collab>on behalf of the RED-HF Committees Investigators</collab></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Amuchastegui</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Belziti</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bluguermann</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Caccavo</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cartasegna</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Colque</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cuneo</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fernandez</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gabito</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goicochea</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gonzalez</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gorosito</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grinfeld</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hominal</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kevorkian</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Litvak Bruno</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Llanos</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mackinnon</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manuale</surname><given-names>O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marzetti</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nul</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Perna</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Riccitelli</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sanchez</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schygiel</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Toblli</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vogel</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aggarwal</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Amerena</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Looze</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fletcher</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hare</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ireland</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Krum</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lattimore</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marwick</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sindone</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Waites</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Altenberger</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ebner</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lenz</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pacher</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Poelzl</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Charlier</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Ceuninck</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Keulenaer</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dendale</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mar&#x000e9;chal</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mullens</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thoeng</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vanderheyden</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vanhaecke</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weytjens</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wollaert</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Albuquerque</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aspe y Rosas</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bocchi</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bordignon</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Clausell</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kaiser</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leaes</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martins Alves</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Montera</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moura</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pereira de Castro</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rassi</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Reis</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saraiva</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Souza Neto</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Benov</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chompalova</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Donova</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Georgiev</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gotchev</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goudev</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grigorov</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Guenova</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hergeldjieva</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ivanov</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kostova</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manolova</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marchev</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nikolov</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Popov</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Raev</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tzekova</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Czarnecki</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Giannetti</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haddad</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heath</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Huynh</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lepage</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lonn</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manyari</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moe</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Parker</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pesant</surname><given-names>Y.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rajda</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ricci</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roth</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sestier</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sluzar</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sussex</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vizel</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Antezana</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bugueno</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Castro</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Conejeros</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manriquez</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martinez</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Potthoff</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stockins</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vukasovic</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gregor</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Herold</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jerabek</surname><given-names>O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jirmar</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kuchar</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Linhart</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Podzemska</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Soucek</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Spac</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Spacek</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vodnansky</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bronnum-Schou</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Clemmensen</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Egstrup</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jensen</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kjoller-Hansen</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kober</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Markenvard</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rokkedal</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Skagen</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Torp-Pedersen</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tuxen</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Videbak</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Laks</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vahula</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Harjola</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kettunen</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kotila</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bauer</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cohen Solal</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Coisne</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Davy</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Groote</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dos Santos</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Funck</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Galinier</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gibelin</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Isnard</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Neuder</surname><given-names>Y.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roul</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sabatier</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Trochu</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Anker</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Denny</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dreykluft</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Flesch</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Genth-Zotz</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hambrecht</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hein</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jeserich</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>John</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kreider-Stempfle</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Laufs</surname><given-names>U.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Muellerleile</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Natour</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sandri</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sch&#x000e4;ufele</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>von Hodenberg</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weyland</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Winkelmann</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tse</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Barsi</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Csikasz</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dezsi</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Edes</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Forster</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karpati</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kerekes</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kis</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kosa</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lupkovics</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nagy</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Preda</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ronaszeki</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tomcsanyi</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zamolyi</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bahl</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bordoloi</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chockalingam</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chopda</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chopra</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dugal</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghaisas</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grant</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hiremath</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iyengar</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jagadeesa Subramania</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Joshi</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mullasari</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Naik</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oomman</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pai</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pareppally Gopal</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Parikh</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Prakash</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sastry</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sathe</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sinha</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Srikanthan</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Subburamakrishnan</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thacker</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wander</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Admon</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Katz</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Klainman</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marmor</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moriel</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mosseri</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shotan</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weinstein</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zimlichman</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agostoni</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Albanese</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Alunni</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bini</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boccanelli</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bolognese</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Campana</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carbonieri</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carpino</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Checco</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cosmi</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>D'Angelo</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Cristofaro</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Floresta</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fucili</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Galvani</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ivleva</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marra</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Musca</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Peccerillo</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Perrone Filardi</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Picchio</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Russo</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Scelsi</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Senni</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tavazzi</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Erglis</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jasinkevica</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kakurina</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Veze</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Volans</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bagdonas</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Berukstis</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Celutkiene</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dambrauskaite</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jarasuniene</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Luksiene</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rudys</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sakalyte</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sliaziene</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aguilar-Romero</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cardona-Mu&#x000f1;oz</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Castro-Jimenez</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chavez-Herrera</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chuquiure Valenzuela</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>De la Pena</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Herrera</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leiva-Pons</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lopez Alvarado</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mendez Machado</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ramos-Lopez</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Basart</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Buijs</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cornel</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Leeuw</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dijkgraaf</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dunselman</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Freericks</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hamraoui</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lenderlink</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Linssen</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lodewick</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lodewijks</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lok</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nierop</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ronner</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Somsen</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Dantzig</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>van der Burgh</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Kempen</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Vlies</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Voors</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wardeh</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Willems</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dickstein</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gundersen</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hole</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thalamus</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Westheim</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dabrowski</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gorski</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Korewicki</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kuc</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miekus</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Musial</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Niegowska</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Piotrowski</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Podolec</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Polonski</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ponikowski</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rynkiewicz</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Szelemej</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Trusz-Gluza</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ujda</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wojciechowski</surname><given-names>D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wysokinski</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Camacho</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fonseca</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Monteiro</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Apetrei</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bruckner</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carasca</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Coman</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Datcu</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dragulescu</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ionescu</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iordachescu-Petica</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manitiu</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Popa</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pop-Moldovan</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Radoi</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stamate</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tomescu</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vita</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aroutiounov</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ballyuzek</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bart</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Churina</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Glezer</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goloshchekin</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ivleva</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kobalava</surname><given-names>Z.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kostenko</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lopatin</surname><given-names>Y.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martynov</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Orlov</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Semernin</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shogenov</surname><given-names>Z.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sidorenko</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Skvortsov</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Storzhakov</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sulimov</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Talibov</surname><given-names>O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tereshenko</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsyrline</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zadionchenko</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zateyshchikov</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dzupina</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hranai</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kmec</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Micko</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Murin</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pella</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sojka</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Spisak</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vahala</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vinanska</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Badat</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bayat</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dawood</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Delport</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ellis</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Garda</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Klug</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mabin</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Naidoo</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pretorius</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ranjith</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Van Zyl</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weich</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Anguita</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Berrazueta</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bruguera i Cortada</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Teresa</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>G&#x000f3;mez S&#x000e1;nchez</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gonz&#x000e1;lez Juanatey</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gonzalez-Maqueda</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jordana</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lupon</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manzano</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pascual Figal</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pulp&#x000f3;n</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Recio</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ridocci Soriano</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez Lambert</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roig Minguell</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roig Minguell</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Romero</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Valdovinos</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Klintberg</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kronvall</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lycksell</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Morner</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rydberg</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Swedberg</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Timberg</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wikstrom</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moccetti</surname><given-names>T.4</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ashok</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Banerjee</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carr-White</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cleland</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Connolly</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Francis</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Greenbaum</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kadr</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lindsay</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McMurray</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Megarry</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Memon</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Murdoch</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Senior</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Squire</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Witte</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Adamson</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Adler</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Altschul</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Altschuller</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Amirani</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Anand</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Andreou</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ansari</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Antonishen</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Banchs</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Banerjee</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Banish</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bank</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Barbagelata</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Barnard</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bellinger</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Benn</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Berk</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Berry</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bethala</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bilazarian</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bisognano</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bleyer</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blum</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boehmer</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bouchard</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boyle</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bozkurt</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Burlew</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Burnham</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Butler</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Call</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cambier</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cappola</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carlson</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandler</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandra</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandraratna</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chernick</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Colan</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Colfer</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Colucci</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Connelly</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Costantini</surname><given-names>O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dadkhah</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dauber</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Denning</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Drazner</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dunlap</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Egbujiobi</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Elkayam</surname><given-names>U.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Elliott</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>El-Shahawy</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Essandoh</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ewald</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farhoud</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Felker</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fernandez</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Festin</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fishbein</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Florea</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Flores</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Floro</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gabris</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Garg</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gatewood</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Geller</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghali</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghumman</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gibbs</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gillespie</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gilmore</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gogia</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goldberg</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gradus-Pizlo</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grainger</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gudmundsson</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gunawardena</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hack</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hall</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hamroff</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hankins</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hanna</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hargrove</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haught</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hauptman</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hazelrigg</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Herzog</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heywood</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hill</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hilton</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hirsch</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hunter</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ibrahim</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Imburgia</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iteld</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jackson</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jaffrani</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>James</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jimenez</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kale</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kaneshige</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kapadia</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karia</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karlsberg</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Katholi</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kerut</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khoury</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kipperman</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Klapholz</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kosinski</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kozinn</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kraus</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Krueger</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Krum</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lader</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Levy</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Light-McGroary</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Loh</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lombardi</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Machado</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Maislos</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mancini</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Markus</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mather</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McCants</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McGrew</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McLaurin</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McMillan</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>McNamara</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Meyer</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Meymandi</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Minami</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Modi</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mody</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mohanty</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moscoso</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moskowitz</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moustafa</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mullen</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Naz</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Noonan</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oellerich</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oren</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pamboukian</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pitt</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Porter</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Prabhu</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Promisloff</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ratkovec</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Richardson</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ross</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saleh</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saltzberg</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sarkar</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schmedtje</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schuyler</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shanes</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Siegel</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Siegel</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Silber</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sklar</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Small</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smull</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sotolongo</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Staniloae</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stapleton</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Steele</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stehlik</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stein</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thadani</surname><given-names>U.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Torre-Amoine</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Trichon</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tummala</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Van Bakel</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vicari</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vijay</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vijayaraghavan</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vittorio</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vossler</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wagoner</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wallis</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ward</surname><given-names>N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Widmer</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wight</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wilkins</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Winchester</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Winkel</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wittmer</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wormer</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wright</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yasin</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zolty</surname><given-names>R.</given-names></name></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK</addr-line></aff><aff id="af2"><label>2</label><addr-line>University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA</addr-line></aff><aff id="af3"><label>3</label><addr-line>Estudios Clinicos Latinoamerica, Rosario, Argentina</addr-line></aff><aff id="af4"><label>4</label><addr-line>ANMCO Research Center, Via la Marmora, Florence, Italy</addr-line></aff><aff id="af5"><label>5</label><addr-line>Duke University Medical Center, Durham, NC, USA</addr-line></aff><aff id="af6"><label>6</label><addr-line>Brigham and Women's Hospital, Boston, MA, USA</addr-line></aff><aff id="af7"><label>7</label><addr-line>Division of Cardiology, Medical University of Silesia, Katowice, Poland</addr-line></aff><aff id="af8"><label>8</label><addr-line>University Medical Center Groningen, Groningen, The Netherlands</addr-line></aff><aff id="af9"><label>9</label><addr-line>Amgen Inc., CA, USA</addr-line></aff><aff id="af10"><label>10</label><addr-line>Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden</addr-line></aff><aff id="af11"><label>11</label><addr-line>Department of Medicine, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA</addr-line></aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Tel: +44 141 330 3479, Fax: +44 141 330 6955, Email: <email>john.mcmurray@glasgow.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>17</day><month>1</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>1</month><year>2013</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>15</volume><issue>3</issue><fpage>334</fpage><lpage>341</lpage><history><date date-type="received"><day>6</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2013. Published by Oxford University Press on behalf of the European Society of Cardiology.</copyright-statement><copyright-year>2013</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="hfs204.pdf"/><abstract><sec><title>Aims</title><p>This report describes the baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) which is testing the hypothesis that anaemia correction with darbepoetin alfa will reduce the composite endpoint of death from any cause or hospital admission for worsening heart failure, and improve other outcomes.</p></sec><sec><title>Methods and results</title><p>Key demographic, clinical, and laboratory findings, along with baseline treatment, are reported and compared with those of patients in other recent clinical trials in heart failure. Compared with other recent trials, RED-HF enrolled more elderly [mean age 70 (SD 11.4) years], female (41%), and black (9%) patients. RED-HF patients more often had diabetes (46%) and renal impairment (72% had an estimated glomerular filtration rate &#x0003c;60 mL/min/1.73 m<sup>2</sup>). Patients in RED-HF had heart failure of longer duration [5.3 (5.4) years], worse NYHA class (35% II, 63% III, and 2% IV), and more signs of congestion. Mean EF was 30% (6.8%). RED-HF patients were well treated at randomization, and pharmacological therapy at baseline was broadly similar to that of other recent trials, taking account of study-specific inclusion/exclusion criteria. Median (interquartile range) haemoglobin at baseline was 112 (106&#x02013;117) g/L.</p></sec><sec><title>Conclusion</title><p>The anaemic patients enrolled in RED-HF were older, moderately to markedly symptomatic, and had extensive co-morbidity.</p></sec></abstract><kwd-group><kwd>Heart failure</kwd><kwd>Anaemia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Numerous studies have shown that anaemia is common in heart failure and is associated with worse outcomes.<sup><xref ref-type="bibr" rid="HFS204C1">1</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C8">8</xref></sup> While some patients have specific, correctable causes of anaemia such as iron deficiency, the exact aetiology of anaemia in most patients with heart failure is unknown, although contributing mechanisms may include renal impairment, inflammation, inadequate production of erythropoietin, and unresponsiveness to erythropoietin.<sup><xref ref-type="bibr" rid="HFS204C9">9</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C12">12</xref></sup> Heart failure patients with anaemia have more severe symptoms and signs, reduced functional capacity, and higher rates of hospitalization and death, compared with heart failure patients without anaemia.<sup><xref ref-type="bibr" rid="HFS204C1">1</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C8">8</xref>,</sup><sup><xref ref-type="bibr" rid="HFS204C13">13</xref>,<xref ref-type="bibr" rid="HFS204C14">14</xref></sup> If anaemia is a mediator and not just a marker of poor outcomes, correcting anaemia could become an important and novel therapeutic target to improve long-term outcomes in such patients. As a result, there has been much interest in whether correcting anaemia might improve outcomes in heart failure.<sup><xref ref-type="bibr" rid="HFS204C15">15</xref>,<xref ref-type="bibr" rid="HFS204C16">16</xref></sup> One treatment shown to increase haemoglobin in anaemic patients with heart failure is the use of an erythropoiesis-stimulating agent (ESA).<sup><xref ref-type="bibr" rid="HFS204C17">17</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C22">22</xref></sup> Studies in experimental animals have also raised the hypothesis that ESAs might also have other potentially beneficial cardiovascular effects.<sup><xref ref-type="bibr" rid="HFS204C23">23</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C25">25</xref></sup> However, it is not known whether ESAs improve clinical outcomes in heart failure, and they have not been shown to reduce cardiovascular events in patients with chronic kidney disease.<sup><xref ref-type="bibr" rid="HFS204C26">26</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C28">28</xref></sup> The Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) is testing the hypothesis that anaemia correction with the ESA darbepoetin will reduce the composite endpoint of death from any cause or hospital admission for worsening heart failure, and improve quality of life and other outcomes.<sup><xref ref-type="bibr" rid="HFS204C29">29</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C31">31</xref></sup> This report describes the baseline characteristics of the patients randomized in RED-HF and considers them in the context of other recently published heart failure trials.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Objectives</title><p>RED-HF is a randomized multicentre double-blind, placebo-controlled, clinical trial designed to determine whether correction of anaemia with the long-acting ESA darbepoetin alfa improves mortality and morbidity in patients with heart failure and anaemia. The details of the design of RED-HF have been described in detail elsewhere.<sup><xref ref-type="bibr" rid="HFS204C30">30</xref></sup> The primary composite outcome is death from any cause or hospitalization for heart failure; change in health-related quality of life, measured using the Overall Summary Score and Symptom Frequency Score from the Kansas City Cardiomyopathy Questionnaire (KCCQ), is a key secondary endpoint.<sup><xref ref-type="bibr" rid="HFS204C32">32</xref></sup></p><p>Briefly, consenting patients aged &#x02265;18 years, in NYHA functional class II&#x02013;IV, with an LVEF &#x02264;40% were eligible if their haemoglobin was between 90 and 120 g/L and they were receiving optimal standard heart failure therapy. Major exclusion criteria included transferrin saturation (TSAT) &#x0003c;15%, evidence of bleeding or other correctable causes of anaemia, serum creatinine &#x0003e;265 &#x000b5;mol/L (&#x0003e;3.0 mg/dL), and blood pressure &#x0003e;160/100 mmHg. Informed consent was obtained before any study-specific procedure. Patients were randomized 1:1 to double-blind subcutaneous placebo or darbepoetin alfa dosed to a haemoglobin target of 130 g/L (and not exceeding 145 g/L). Randomization was stratified by region and by the presence or absence of an implantable cardioverter defibrillator (ICD), and/or CRT.</p></sec><sec id="s2b"><title>Statistical analysis</title><p>The RED-HF is an event-driven study, such that assuming an annualized placebo event rate of 25%. Approximately 1150 subjects with primary endpoint events will be needed to detect a 20% difference between treatment groups with 80% power with adjustments for treatment effect attenuation. The protocol originally assumed that the study would enrol approximately 2600 subjects. Because the actual enrolment duration was longer than originally anticipated, 2278 subjects were actually enrolled to accrue the approximately1150 primary endpoints.</p><p>All randomized subjects are included in the present analysis. Descriptive summary statistics in the form of mean and standard deviation (SD) or median and first (Q1) and third quartiles (Q3) are provided for continuous baseline variables, and percentage of total were generated for categorical baseline variables. Estimated glomerular filtration rate (eGFR) was calculated using the four-variable Modification of Diet in Renal Disease (MDRD) equation for IDMS (isotope dilution mass spectrometry)-calibrated serum creatinine: eGFR (mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup>) = 175 &#x000d7; [serum creatinine in mg/dL]<sup>&#x02212;1.154</sup> &#x000d7;age<sup>&#x02212;0.203</sup> &#x000d7;1.212 [if black] &#x000d7; 0.742 [if female].</p><p>Descriptive summary statistics are provided using SAS<sup>&#x000ae;</sup> software version 9.2. No statistical comparisons have been made.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Enrolment</title><p>Between 13 June 2006 and 4 May 2012, a total of 2278 patients were randomized at 453 sites in 33 countries representing all major regions of the world. The three regions with the greatest contribution were North America (<italic>n</italic> = 644), Western Europe (<italic>n</italic> = 609), and Central/Eastern Europe (<italic>n</italic> = 454). The three countries with the largest enrolment were the USA (<italic>n</italic> = 601), India (<italic>n</italic> = 299), and Russia (<italic>n</italic> = 105). The mean number of patients enrolled per site was 5.0 (range per country from 1.3 to 11.1).</p></sec><sec id="s3b"><title>Baseline demographics</title><p><italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB1">1</xref></italic> shows the baseline characteristics of the patients in RED-HF compared with those of patients in other recently published heart failure trials.<sup><xref ref-type="bibr" rid="HFS204C33">33</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C36">36</xref></sup> At baseline, patients in RED-HF were older, a much larger proportion were women, and more were black than in the other trials. Patients in RED-HF also had a longer duration of heart failure than reported in previous trials.
<table-wrap id="HFS204TB1" position="float"><label>Table 1</label><caption><p>Baseline characteristics and treatment in RED-HF and other recent trials</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">EMPHASIS-HF (<italic>n</italic> = 2737)</th><th align="left" rowspan="1" colspan="1">SHIFT (<italic>n</italic> = 6505)</th><th align="left" rowspan="1" colspan="1">RAFT (<italic>n</italic> = 1798)</th><th align="left" rowspan="1" colspan="1">HEAAL<sup>a</sup> (<italic>n</italic> = 3834)</th><th align="left" rowspan="1" colspan="1">RED-HF (<italic>n</italic> = 2278)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (mean)</td><td rowspan="1" colspan="1">69</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">70 (11.4)</td></tr><tr><td rowspan="1" colspan="1">Female sex (%)</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">41</td></tr><tr><td rowspan="1" colspan="1">NYHA class (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;II</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">69</td><td rowspan="1" colspan="1">35</td></tr><tr><td rowspan="1" colspan="1">&#x02003;III</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">63</td></tr><tr><td rowspan="1" colspan="1">&#x02003;IV</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">Race (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;White</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">89</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">68</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Black</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Asian</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Other</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">9</td></tr><tr><td rowspan="1" colspan="1">Heart rate (mean)</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">72 (11.2)</td></tr><tr><td rowspan="1" colspan="1">BP (mean)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Systolic</td><td rowspan="1" colspan="1">124</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">120 (18.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Diastolic</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">69 (11.0)</td></tr><tr><td rowspan="1" colspan="1">LVEF (mean)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">30 (6.8)</td></tr><tr><td rowspan="1" colspan="1">QRS duration (mean)</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">121 (39.4)</td></tr><tr><td rowspan="1" colspan="1">BMI (mean)</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">27 (5.7)</td></tr><tr><td rowspan="1" colspan="1">Principal cause of HF (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;IHD</td><td rowspan="1" colspan="1">69</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">72</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Non-IHD</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">28</td></tr><tr><td rowspan="1" colspan="1">Duration of HF (years)</td><td rowspan="1" colspan="1">4.7</td><td rowspan="1" colspan="1">3.5</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">5.3 (5.4)</td></tr><tr><td rowspan="1" colspan="1">Medical history (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Hospitalization for HF</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">100<sup>b</sup></td><td rowspan="1" colspan="1">25<sup>c</sup></td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">87 (37<sup>c</sup>)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hypertension</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">74</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Angina pectoris</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">65 (IHD)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unstable angina</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Myocardial infarction</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">54</td></tr><tr><td rowspan="1" colspan="1">&#x02003;PCI</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">28</td></tr><tr><td rowspan="1" colspan="1">&#x02003;CABG</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">28</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Atrial fibrillation/flutter</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">8<sup>d</sup></td><td rowspan="1" colspan="1">13<sup>e</sup></td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LBBB<sup>f</sup></td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">19</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Diabetes mellitus</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">46</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Stroke</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Current smoker</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">Renal function</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Serum creatinine (&#x003bc;mol/L)</td><td rowspan="1" colspan="1">102</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">131 (49.3)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;eGFR mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup> (mean)</td><td rowspan="1" colspan="1">71</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">50 (21.3)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;eGFR &#x0003c;60 mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup> (%)</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">72</td></tr><tr><td rowspan="1" colspan="1">Treatment (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Diuretic</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">91</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ACEi</td><td rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">63</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ARB</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">28</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ACEi, ARB, or both</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">89</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Beta-blocker</td><td rowspan="1" colspan="1">87</td><td rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">85</td></tr><tr><td rowspan="1" colspan="1">&#x02003;MRA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">42<sup>g</sup></td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">45</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Digoxin</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">29</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Antithrombotic</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Vitamin K antagonist</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">34<sup>h</sup></td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Antiplatelet</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Aspirin</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">51</td><td rowspan="1" colspan="1">58</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Clopidogrel</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;Any</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">66</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Antithrombotic or antiplatelet</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">84</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Lipid lowering</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">58<sup>i</sup></td><td rowspan="1" colspan="1">68<sup>i</sup></td><td rowspan="1" colspan="1">39<sup>i</sup></td><td rowspan="1" colspan="1">62<sup>i</sup></td></tr><tr><td rowspan="1" colspan="1">&#x02003;CRT</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ICD</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">&#x02003;CRT-D</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">9</td></tr></tbody></table><table-wrap-foot><fn><p>ACEi, ACE inhibitor; BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft; eGFR, estimated glomerular filtration rate; HF, heart failure; ICD, implantable cardioverter defibrillator; IHD, ischaemic heart disease; MRA, mineralocorticoid receptor antagonist; NA, not applicable.</p></fn><fn><p><sup>a</sup>Median.</p></fn><fn><p><sup>b</sup>Per protocol, all patients had an admission for worsening heart failure within 12 months.</p></fn><fn><p><sup>c</sup>In previous 6 months.</p></fn><fn><p><sup>d</sup>Current AF excluded.</p></fn><fn><p><sup>e</sup>Permanent AF at baseline.</p></fn><fn><p><sup>f</sup>Non-paced.</p></fn><fn><p><sup>g</sup>Spironolactone.</p></fn><fn><p><sup>h</sup>Warfarin.</p></fn><fn><p><sup>i</sup>Statin.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s3c"><title>Co-morbidities</title><p>Two co-morbidities were more common at baseline in RED-HF, specifically diabetes mellitus and impaired renal function (eGFR &#x0003c;60 mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup>). The only other notable difference was the much smaller proportion of current smokers in RED-HF, compared with the other trials. In addition to the co-morbidities shown in <italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB1">1</xref></italic>, 8% of patients had a history of cancer.</p></sec><sec id="s3d"><title>Functional capacity and heart failure signs</title><p>At baseline, a greater proportion of patients in RED-HF were in NYHA functional class III or IV than in the other recent trials. As shown in <italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB2">2</xref></italic>, more patients in RED-HF had signs of congestion than those in other trials.<sup><xref ref-type="bibr" rid="HFS204C37">37</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C40">40</xref></sup>
<table-wrap id="HFS204TB2" position="float"><label>Table&#x000a0;2</label><caption><p>Clinical signs in RED-HF and other heart failure trials</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Peripheral oedema (%)</th><th align="left" rowspan="1" colspan="1">Lung crackles/rales (%)</th><th align="left" rowspan="1" colspan="1">Jugular venous distension (%)</th><th align="left" rowspan="1" colspan="1">Third heart sound (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">RED-HF (<italic>n</italic> = 2278)</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">CARE-HF (<italic>n</italic> = 813)</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">COMET (<italic>n</italic> = 3029)</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">19</td></tr><tr><td rowspan="1" colspan="1">MERIT-HF (<italic>n</italic> = 3991)</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">23</td></tr><tr><td rowspan="1" colspan="1">CHARM-Added (<italic>n</italic> = 2548)</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">15<sup>a</sup></td><td rowspan="1" colspan="1">11<sup>b</sup></td><td rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">CHARM-Alt. (<italic>n</italic> = 2028)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">16<sup>a</sup></td><td rowspan="1" colspan="1">10<sup>b</sup></td><td rowspan="1" colspan="1">16</td></tr></tbody></table><table-wrap-foot><fn><p>Alt., Alternative; NR, not reported.</p></fn><fn><p><sup>a</sup>Basilar.</p></fn><fn><p><sup>b</sup> &#x0003e; 6 cm.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s3e"><title>Quality of life</title><p><italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB3">3</xref></italic> shows KCCQ scores for patients in RED-HF, compared with those of patients in other recently published trials. The baseline Overall Summary Score and Clinical Summary Score for RED-HF patients was 56.1 and 59.4, respectively. These are consistent with patients in RED-HF having moderate to severe heart failure.<sup><xref ref-type="bibr" rid="HFS204C34">34</xref>,<xref ref-type="bibr" rid="HFS204C41">41</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C44">44</xref></sup>
<table-wrap id="HFS204TB3" position="float"><label>Table&#x000a0;3</label><caption><p>Baseline mean (SD) Kansas City Cardiomyopathy Questionnaire Overall Summary Scores and Clinical Summary Scores in RED-HF and other recent trials</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">MADIT-CRT (<italic>n</italic> = 1820)</th><th align="left" rowspan="1" colspan="1">HF-ACTION (<italic>n</italic> = 2331)</th><th align="left" rowspan="1" colspan="1">SHIFT (<italic>n</italic> = 6505)</th><th align="left" rowspan="1" colspan="1">RED-HF (<italic>n</italic> = 2278)</th><th align="left" rowspan="1" colspan="1">STICH (<italic>n</italic> = 1212)</th><th align="left" rowspan="1" colspan="1">Heart-Mate II (<italic>n</italic> = 200)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">OSS</td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">56 (22.5)</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">CSS</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">59 (22.4)</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">34</td></tr></tbody></table><table-wrap-foot><fn><p>CSS, Clinical Summary Score; OSS, Overall Summary Score.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s3f"><title>Baseline treatment</title><p>Overall, the patients were well treated at randomization and the pharmacological therapy at baseline was broadly similar to other recent trials, taking account of study-specific inclusion/exclusion criteria (<italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB1">1</xref></italic>). Of note, use of antithrombotic and antiplatelet therapy was not more common in RED-HF than in the other trials. ICD and CRT use was also consistent with other recent trials. However, device use was greater in North America and Western Europe than elsewhere (<italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB4">4</xref></italic>).
<table-wrap id="HFS204TB4" position="float"><label>Table&#x000a0;4</label><caption><p>Type of device used by region</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">North America (<italic>n</italic> = 644), <italic>n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Latin America (<italic>n</italic> = 262), <italic>n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Western Europe/AUS/RSA/Israel (<italic>n</italic> = 609), <italic>n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Eastern Europe/Russia (<italic>n</italic> = 454), <italic>n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Asia (<italic>n</italic> = 309), <italic>n</italic> (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CRT only</td><td rowspan="1" colspan="1">8 (1)</td><td rowspan="1" colspan="1">4 (2)</td><td rowspan="1" colspan="1">19 (3)</td><td rowspan="1" colspan="1">3 (1)</td><td rowspan="1" colspan="1">4 (1)</td></tr><tr><td rowspan="1" colspan="1">CRT-D</td><td rowspan="1" colspan="1">133 (21)</td><td rowspan="1" colspan="1">1 (&#x0003c;1)</td><td rowspan="1" colspan="1">70 (11)</td><td rowspan="1" colspan="1">6 (1)</td><td rowspan="1" colspan="1">4 (1)</td></tr><tr><td rowspan="1" colspan="1">ICD</td><td rowspan="1" colspan="1">214 (33)</td><td rowspan="1" colspan="1">8 (3)</td><td rowspan="1" colspan="1">72 (12)</td><td rowspan="1" colspan="1">12 (3)</td><td rowspan="1" colspan="1">3 (1)</td></tr><tr><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">289 (45)</td><td rowspan="1" colspan="1">249 (95)</td><td rowspan="1" colspan="1">448 (74)</td><td rowspan="1" colspan="1">433 (95)</td><td rowspan="1" colspan="1">298 (96)</td></tr></tbody></table><table-wrap-foot><fn><p>AUS, Australia; RSA, Republic of South Africa; Asia, India and Hong Kong; Latin America, Argentina, Brazil, Chile, and Mexico.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s3g"><title>Haematological and other laboratory measurements</title><p>Apart from haemoglobin, haematocrit, and erythrocyte count which were reduced, as expected, the median values for other haematological indices were within the normal range, as were vitamin B<sub>12</sub> and folate levels (<italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB5">5</xref></italic>). The proportion of women with serum iron, total iron-binding capacity (TIBC), ferritin, and TSAT within the normal range (97, 94, 88, and 97%, respectively) was numerically higher than for men (89, 92, 83, and 73%, respectively). The notable difference in proportion with a normal TSAT reflects the higher lower limit of normal for men (20% vs. 15% in women) and the eligibility TSAT criterion ( &#x02265;15%).<sup><xref ref-type="bibr" rid="HFS204C30">30</xref></sup> Blood chemistry was largely as anticipated, with an elevated urea (blood urea nitrogen) in keeping with the high prevalence of subjects with a low eGFR.
<table-wrap id="HFS204TB5" position="float"><label>Table&#x000a0;5</label><caption><p>Baseline laboratory measurements in RED-HF</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char=" " span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Measurement</th><th align="left" rowspan="1" colspan="1">Median (Q1, Q3)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Haematology</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Haemoglobin (g/L)</td><td rowspan="1" colspan="1">112 (106, 117)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Haematocrit (%)</td><td rowspan="1" colspan="1">0.34 (0.33, 0.36)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;White cells (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">6.5 (5.3, 7.9)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Red cells (10<sup>12</sup>/L)</td><td rowspan="1" colspan="1">5.3 (4.4, 6.1)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Platelets (10<sup>9</sup>/L)</td><td rowspan="1" colspan="1">224 (179, 275)</td></tr><tr><td rowspan="1" colspan="1">Iron indices</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Serum iron (&#x003bc;mol/L)</td><td rowspan="1" colspan="1">12.2 (9.8, 15.8)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIBC (&#x003bc;mol/L)</td><td rowspan="1" colspan="1">50.5 (44.8, 56.7)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ferritin (&#x003bc;g/L)</td><td rowspan="1" colspan="1">102 (53, 194)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TSAT (%)</td><td rowspan="1" colspan="1">24 (19, 31)</td></tr><tr><td rowspan="1" colspan="1">Vitamin levels</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Vitamin B<sub>12</sub> (pmol/L)</td><td rowspan="1" colspan="1">286 (206, 454)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Serum folate (nmol/L)</td><td rowspan="1" colspan="1">24 (14, 56)</td></tr><tr><td rowspan="1" colspan="1">Blood chemistry</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Sodium (mmol/L)</td><td rowspan="1" colspan="1">140 (138, 142)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Potassium (mmol/L)</td><td rowspan="1" colspan="1">4.5 (4.2, 4.9)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Magnesium (mmol/L)</td><td rowspan="1" colspan="1">0.9 (0.8, 1.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;BUN/urea (mmol/L)</td><td rowspan="1" colspan="1">10.4 (7.1, 15.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Uric acid (&#x003bc;mol/L)</td><td rowspan="1" colspan="1">440 (357, 547)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Albumin (g/L)</td><td rowspan="1" colspan="1">39 (36, 42)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Calcium (mmol/L)</td><td rowspan="1" colspan="1">2.4 (2.3, 2.5)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Phosphorus (mmol/L)</td><td rowspan="1" colspan="1">1.2 (1.1, 1.3)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Glucose (mmol/L)</td><td rowspan="1" colspan="1">6.1 (5.3, 8.4)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HbA<sub>1c</sub> (%)</td><td rowspan="1" colspan="1">6.0 (5.6, 7.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mmol/L)</td><td rowspan="1" colspan="1">4.1 (3.4, 4.9)</td></tr></tbody></table><table-wrap-foot><fn><p>BUN, blood urea nitrogen; HbA<sub>1c</sub>, glycated haemoglobin; TIBC, total iron-binding capacity; TSAT, transferrin saturation.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Comparison of patient baseline characteristics across trials has to be made cautiously because these are partly determined by protocol inclusion and exclusion criteria and geographical factors, as well as the time period during which the trial was recruited (as the standard of care changes with time). Nevertheless, there are some differences between patients in RED-HF and those in other trials that almost certainly reflect the impact of anaemia. For example, patients enrolled in RED-HF are older than in most previous trials with a similar inclusion age range, and RED-HF has a much higher proportion of females than previous studies in systolic heart failure. These characteristics are consistent with the finding that anaemia is more common in older subjects and women in general, and in heart failure specifically. Similarly, anaemia is associated with worse functional class (although it is not known which is the &#x02018;chicken&#x02019; and which is the &#x02018;egg&#x02019;). In keeping with this, we found that a higher proportion of patients in RED-HF were in NYHA class III and IV at baseline than in other recent trials. In addition, RED-HF patients had more signs of congestion, particularly peripheral oedema, than reported in previous studies. The KCCQ Overall and Clinical Summary Scores in RED-HF were consistent with generally worse clinical status than in several recent heart failure trials, including MADIT-CRT, SHIFT, and HF-ACTION (although the scores were not as low as in the Heart Mate II trial which enrolled patients with advanced heart failure ineligible for transplantation).<sup><xref ref-type="bibr" rid="HFS204C34">34</xref>,<xref ref-type="bibr" rid="HFS204C41">41</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C44">44</xref></sup></p><p>Diabetes and impaired renal function are associated with an increased risk of anaemia, and we found both these co-morbidities to be more common in RED-HF than in the other studies described.<sup><xref ref-type="bibr" rid="HFS204C1">1</xref>,<xref ref-type="bibr" rid="HFS204C9">9</xref>,<xref ref-type="bibr" rid="HFS204C10">10</xref></sup> Anaemia is also more prevalent in black individuals, and RED-HF has enrolled more black patients than in other recent trials.<sup><xref ref-type="bibr" rid="HFS204C1">1</xref>,<xref ref-type="bibr" rid="HFS204C9">9</xref>,<xref ref-type="bibr" rid="HFS204C10">10</xref></sup> This could also reflect the higher proportion of US subjects in RED-HF than in the other studies. The longer average duration of heart failure in patients in RED-HF is also consistent with the notion that anaemia is more common in more advanced heart failure (in addition to the studies shown in <italic>Table&#x000a0;<xref ref-type="table" rid="HFS204TB1">1</xref></italic>, the duration of heart failure was 3.1 years in BEST and 4.3 years in Val-HeFT).<sup><xref ref-type="bibr" rid="HFS204C1">1</xref>,<xref ref-type="bibr" rid="HFS204C9">9</xref>,<xref ref-type="bibr" rid="HFS204C10">10</xref></sup></p><p>Most other characteristics at baseline did not differ strikingly between patients in RED-HF and other study populations. The one exception was the lower prevalence of smoking in RED-HF. Although this could be a chance finding (or due to under-reporting of smoking in certain regions/cultures), review of current smoking rates in five other trials showed a prevalence which ranged from 10.6% to 17.5%.<sup><xref ref-type="bibr" rid="HFS204C5">5</xref>,<xref ref-type="bibr" rid="HFS204C38">38</xref>&#x02013;<xref ref-type="bibr" rid="HFS204C40">40</xref>,</sup><sup><xref ref-type="bibr" rid="HFS204C45">45</xref></sup> The prevalence of smoking in RED-HF may, therefore, be unusually low, possibly reflecting the association between smoking and higher haemoglobin levels.</p><p>Baseline use of an ACE inhibitor (or ARB) and beta-blocker in RED-HF was high and consistent with the use of these drugs in other recent trials. Mineralocorticoid receptor antagonist (MRA) use at baseline was not as high as in SHIFT, but all patients in that trial had recently been hospitalized, i.e. probably recently in NYHA class IV and with a firm indication for an MRA.<sup><xref ref-type="bibr" rid="HFS204C34">34</xref></sup> The majority were also enrolled in Europe and none in the USA; MRA use is generally lower in the USA compared with Europe (and RED-HF enrolled a high proportion of patients in the USA). The higher prevalence of renal dysfunction in RED-HF may also have limited use of MRAs.</p><p>One other recent trial also makes for an interesting comparison with RED-HF. FAIR-HF enrolled 459 patients with NYHA functional class II or III heart failure, an LVEF &#x02264;40% (for patients with NYHA class II) or &#x02264;45% (for NYHA class III), iron deficiency (defined as a ferritin level &#x0003c;100 &#x000b5;g/L or between 100 and 299 &#x000b5;g/L, if the TSAT was &#x0003c;20%), and a haemoglobin level of 9.5&#x02013;13.5 g/dL.<sup><xref ref-type="bibr" rid="HFS204C46">46</xref></sup> Patients were randomized 1:2 to i.v. saline or i.v. iron. At baseline, the mean level of ferritin in FAIR-HF was 55 &#x000b5;g/L (compared with 156 &#x000b5;g/L in RED-HF), TSAT 17.4% (compared with 26.9%), and haemoglobin 11.9 g/dL (compared with 11.0 g/dL). Patients in FAIR-HF had a higher average eGFR at baseline (64 mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup>) compared with those in RED-HF (50 mL/min/1.73 m<sup><xref ref-type="bibr" rid="HFS204C2">2</xref></sup>).</p><p>In summary, the patients enrolled in RED-HF exhibit the expected greater functional impairment and co-morbidities found in patients with anaemia in addition to heart failure and are well treated with conventional evidence-based therapy. Therefore, RED-HF is well placed to answer the question of whether or not the addition of darbepoetin alfa to standard therapy will have an incremental benefit in patients with systolic heart failure and anaemia.</p></sec><sec id="s5"><title>Funding</title><p>RED-HF is funded by Amgen Inc.</p><p><bold>Conflict of interest:</bold> Glasgow University is compensated for time spent by J.J.V.McM working as a Steering Committee member for the RED-HF and TREAT trials. I.S.A. is a member of the RED-HF Steering Committee. A.P.M and C.O. have no conflicts to declare. M.A.P. has received grant support (research grant to the Brigham and Women's Hospital) for conduct of TREAT and for services to the RED-HF Executive Committee, and received a consulting fee in 2008. M.A., S.C., and D.S. are employees of Amgen, and are currently engaged in research conducted by Amgen. S.D.S. conducts research sponsored by Amgen and has consulted for Amgen. K.S. is a consultant to Amgen and receives research support from Amgen as co-Principal Investigator of the RED-HF trial. M.T. has received honoraria from Amgen for participation in the RED-HF Steering Committee. D.J. van V. has received Board Membership fees and his department has received unrestricted research grants from Amgen. J.B.Y. is a consultant to Amgen and receives research support from Amgen as co-Principal Investigator of the RED-HF trial.</p></sec></body><back><app-group><app><title>Appendix: RED-HF trial investigators</title><p>Argentina (82 patients): M. Amuchastegui, C. Belziti, J. Bluguermann, M. Caccavo, L. Cartasegna, R. Colque, C. Cuneo, A. Fernandez, A. Gabito, R. Goicochea, M. Gonzalez, V. Gorosito, L. Grinfeld, M. Hominal, R. Kevorkian, M. Litvak Bruno, J. Llanos, I. Mackinnon, O. Manuale, E. Marzetti, D. Nul, E. Perna, M. Riccitelli, A. Sanchez, D. Santos, P. Schygiel, J. Toblli, D. Vogel.</p><p>Australia (23 patients): A. Aggarwal, J. Amerena, F. De Looze, P. Fletcher, D. Hare, M. Ireland, H. Krum, J. Lattimore, T. Marwick, A. Sindone, P. Thompson, J. Waites.</p><p>Austria (8 patients): J. Altenberger, C. Ebner, K. Lenz, R. Pacher, G. Poelzl.</p><p>Belgium (70 patients): F. Charlier, M. de Ceuninck, G. De Keulenaer, P. Dendale, P. Mar&#x000e9;chal, W. Mullens, J. Thoeng, M. Vanderheyden, J. Vanhaecke, C. Weytjens, B. Wollaert.</p><p>Brazil (69 patients): D. Albuquerque, D. Almeida, J. Aspe y Rosas, E. Bocchi, S. Bordignon, N. Clausell, S. Kaiser, P. Leaes, S. Martins Alves, M. Montera, L. Moura, R. Pereira de Castro, S. Rassi, A. Reis, J. Saraiva, M. Sim&#x000f5;es, J. Souza Neto, M. Teixeira.</p><p>Bulgaria (90 patients): H. Benov, B. Chompalova, T. Donova, P. Georgiev, D. Gotchev, A. Goudev, M. Grigorov, D. Guenova, V. Hergeldjieva, D. Ivanov, E. Kostova, A. Manolova, S. Marchev, F. Nikolov, A. Popov, D. Raev, M. Tzekova.</p><p>Canada (43 patients): W. Czarnecki, N. Giannetti, H. Haddad, J. Heath, T. Huynh, S. Lepage, P . Liu, E. Lonn, P. Ma, D. Manyari, G. Moe, J. Parker, Y. Pesant, M. Rajda, J. Ricci, S. Roth, F. Sestier, V. Sluzar, B. Sussex, S. Vizel.</p><p>Chile (14 patients): G. Antezana, C. Bugueno, P. Castro, C. Conejeros, L. Manriquez, D. Martinez, S. Potthoff, B. Stockins, J. Vukasovic.</p><p>Czech Republic (15 patients): P. Gregor, M. Herold, O. Jerabek, R. Jirmar, R. Kuchar, A. Linhart, B. Podzemska, M. Soucek, J. Spac, R. Spacek, P. Vodnansky.</p><p>Denmark (29 patients): J. Bronnum-Schou, K. Clemmensen, K. Egstrup, G. Jensen, L. Kjoller-Hansen, L. Kober, J. Markenvard, J. Rokkedal, K. Skagen, C. Torp-Pedersen, C. Tuxen, L. Videbak.</p><p>Estonia (6 patients): T. Laks, V. Vahula.</p><p>Finland (0 patients): V. Harjola, R. Kettunen, M. Kotila.</p><p>France (48 patients): F. Bauer, A. Cohen Solal, D. Coisne, J. Davy, P. De Groote, P. Dos Santos, F. Funck, M. Galinier, P. Gibelin, R. Isnard, Y. Neuder, G. Roul, R. Sabatier, J. Trochu.</p><p>Germany (99 patients): S. Anker, S. Denny, T. Dreykluft, M. Flesch, S. Genth-Zotz, R. Hambrecht, J. Hein, M. Jeserich, M. John, H. Kreider-Stempfle, U. Laufs, K. Muellerleile, M. Natour, M. Sandri, T. Sch&#x000e4;ufele, E. von Hodenberg, K. Weyland, B. Winkelmann.</p><p>Hong Kong SAR (10 patients): H. Tse, B. Yan.</p><p>Hungary (8 patients): B. Barsi, J. Csikasz, C. Dezsi, I. Edes, T. Forster, P. Karpati, C. Kerekes, E. Kis, I. Kosa, G. Lupkovics, A. Nagy, I. Preda, A. Ronaszeki, J. Tomcsanyi, K. Zamolyi.</p><p>India (299 patients): D. Agarwal, V. Bahl, A. Bordoloi, K. Chockalingam, M. Chopda, V. Chopra, J. Dugal, N. Ghaisas, S. Ghosh, P. Grant, S. Hiremath, S. Iyengar, B. Jagadeesa Subramania, P. Jain, A. Joshi, A. Khan, A. Mullasari, S. Naik, A. Oomman, V. Pai, R. Pareppally Gopal, K. Parikh, T. Patel, V. Prakash, B. Sastry, S. Sathe, N. Sinha, V. Srikanthan, P. Subburamakrishnan, H. Thacker, G. Wander.</p><p>Israel (37 patients): D. Admon, A. Katz, E. Klainman, B. Lewis, A. Marmor, M. Moriel, M. Mosseri, A. Shotan, J. Weinstein, R. Zimlichman.</p><p>Italy (51 patients): P. Agostoni, M. Albanese, G. Alunni, R. Bini, A. Boccanelli, L. Bolognese, C. Campana, E. Carbonieri, C. Carpino, L. Checco, F. Cosmi, G. D'Angelo, M. De Cristofaro, A. Floresta, A. Fucili, M. Galvani, A. Ivleva, S. Marra, G. Musca, N. Peccerillo, P. Perrone Filardi, E. Picchio, T. Russo, L. Scelsi, M. Senni, L. Tavazzi.</p><p>Latvia (20 patients): A. Erglis, I. Jasinkevica, N. Kakurina, I. Veze, E. Volans.</p><p>Lithuania (30 patients): A. Bagdonas, E. Berukstis, J. Celutkiene, A. Dambrauskaite, D. Jarasuniene, D. Luksiene, A. Rudys, G. Sakalyte, S. Sliaziene.</p><p>Mexico (97 patients): R. Aguilar-Romero, J. Aspe y Rosas, E. Cardona-Mu&#x000f1;oz, J. Castro-Jimenez, J. Chavez-Herrera, E. Chuquiure Valenzuela, G. De la Pena, E. Herrera, J. Leiva-Pons, A. Lopez Alvarado, G. Mendez Machado, G. Ramos-Lopez.</p><p>The Netherlands (64 patients): D. Basart, E. Buijs, J. Cornel, M. de Leeuw, R. Dijkgraaf, P. Dunselman, M. Freericks, K. Hamraoui, T. Lenderlink, G. Linssen, P. Lodewick, C. Lodewijks, D. Lok, P. Nierop, E. Ronner, A. Somsen, J. van Dantzig, P. van der Burgh, L. van Kempen, B. van Vlies, A. Voors, A. Wardeh, F. Willems.</p><p>Norway (17 patients): K. Dickstein, T. Gundersen, T. Hole, J. Thalamus, A. Westheim.</p><p>Poland (92 patients): M. Dabrowski, J. Gorski, J. Korewicki, K. Kuc, P. Miekus, W. Musial, J. Niegowska, W. Piotrowski, P. Podolec, L. Polonski, P. Ponikowski, A. Rynkiewicz, R. Szelemej, M. Trusz-Gluza, M. Ujda, D Wojciechowski, A. Wysokinski.</p><p>Portugal (14 patients): A. Camacho, C. Fonseca, P. Monteiro.</p><p>Romania (26 patients): E. Apetrei, I. Bruckner, E. Carasca, I. Coman, M. Datcu, S. Dragulescu, P. Ionescu, D. Iordachescu-Petica, I. Manitiu, V. Popa, A. Pop-Moldovan, M. Radoi, S. Stamate, M. Tomescu, I. Vita.</p><p>Russia (105 patients): G. Aroutiounov, M. Ballyuzek, B. Bart, S. Churina, M. Glezer, B. Goloshchekin, A. Ivleva, Z. Kobalava, V. Kostenko, Y. Lopatin, A. Martynov, V. Orlov, E. Semernin, Z. Shogenov, B. Sidorenko, A. Skvortsov, G. Storzhakov, V. Sulimov, O. Talibov, S. Tereshenko, V. Tsyrline, V. Zadionchenko, D. Zateyshchikov.</p><p>Slovakia (62 patients): A. Dzupina, M. Hranai, J. Kmec, K. Micko, J. Murin, D. Pella, G. Sojka, V. Spisak, P. Vahala, D. Vinanska.</p><p>South Africa (25 patients): A. Badat, J. Bayat, S. Dawood, E. Delport, G. Ellis, R. Garda, E. Klug, T. Mabin, D. Naidoo, M. Pretorius, N. Ranjith, L. Van Zyl, H. Weich.</p><p>Spain (40 patients): M. Anguita, J. Berrazueta, J. Bruguera i Cortada, E. de Teresa, M. G&#x000f3;mez S&#x000e1;nchez, J. Gonz&#x000e1;lez Juanatey, I. Gonzalez-Maqueda, R. Jordana, J. Lupon, L. Manzano, D. Pascual Figal, L. Pulp&#x000f3;n, J. Recio, F. Ridocci Soriano, J. Rodr&#x000ed;guez Lambert, E. Roig Minguell, E. Roig Minguell, J. Romero, P. Valdovinos.</p><p>Sweden (19 patients): L. Klintberg, T. Kronvall, M. Lycksell, S. Morner, E. Rydberg, K. Swedberg, I. Timberg, G. Wikstrom</p><p>Switzerland (0 patients): T.4 Moccetti.</p><p>UK (65 patients): J. Ashok, P. Banerjee, G. Carr-White, J. Cleland, E. Connolly, M. Francis, R. Greenbaum, H. Kadr, S. Lindsay, J. McMurray, S. Megarry, A. Memon, D. Murdoch, R. Senior, I. Squire, L. Tan, K. Witte.</p><p>USA (601 patients): K. Adams, P. Adamson, A. Adler, L. Altschul, A. Altschuller, H. Amirani, I. Anand, C. Andreou, M. Ansari, M. Antonishen, H. Banchs, S. Banerjee, D. Banish, A. Bank, A. Barbagelata, D. Barnard, R. Bellinger, A. Benn, M. Berk, B. Berry, V. Bethala, S. Bilazarian, J. Bisognano, F. Bleyer, M. Blum, J. Boehmer, A. Bouchard, A. Boyle, B. Bozkurt, C. Brown, B. Burlew, K. Burnham, J. Butler, J. Call, P. Cambier, T. Cappola, R. Carlson, B. Chandler, R. Chandra, P. Chandraratna, R. Chernick, D. Colan, H. Colfer, W. Colucci, T. Connelly, O. Costantini, S. Dadkhah, I. Dauber, J. Davis, S. Davis, S. Denning, M. Drazner, S. Dunlap, L. Egbujiobi, U. Elkayam, J. Elliott, M. El-Shahawy, L. Essandoh, G. Ewald, J. Fang, H. Farhoud, G. Felker, J. Fernandez, R. Festin, G. Fishbein, V. Florea, E. Flores, J. Floro, M. Gabris, M. Garg, R. Gatewood, M. Geller, J. Ghali, W. Ghumman, G. Gibbs, E. Gillespie, R. Gilmore, H. Gogia, L. Goldberg, I. Gradus-Pizlo, T. Grainger, G. Gudmundsson, D. Gunawardena, D. Gupta, T. Hack, S. Hall, G. Hamroff, S. Hankins, M. Hanna, J. Hargrove, W. Haught, P. Hauptman, M. Hazelrigg, C. Herzog, J. Heywood, T. Hill, T. Hilton, H. Hirsch, J. Hunter, H. Ibrahim, M. Imburgia, B. Iteld, B. Jackson, N. Jaffrani, D. Jain, A. Jain, M. James, J. Jimenez, E. Johnson, P. Kale, A. Kaneshige, S. Kapadia, D. Karia, R. Karlsberg, R. Katholi, E. Kerut, W. Khoury, R. Kipperman, M. Klapholz, E. Kosinski, M. Kozinn, D. Kraus, S. Krueger, H. Krum, S. Kumar, E. Lader, C. Lee, W. Levy, E. Lewis, K. Light-McGroary, I. Loh, W. Lombardi, C. Machado, F. Maislos, D. Mancini, T. Markus, P. Mather, K. McCants, F. McGrew, B. McLaurin, E. McMillan, D. McNamara, T. Meyer, S. Meymandi, A. Miller, E. Minami, M. Modi, F. Mody, P. Mohanty, R. Moscoso, R. Moskowitz, M. Moustafa, M. Mullen, T. Naz, T. Noonan, T. O'Brien, W. Oellerich, R. Oren, S. Pamboukian, N. Pereira, W. Pitt, C. Porter, S. Prabhu, S. Promisloff, R. Ratkovec, R. Richardson, A. Ross, N. Saleh, M. Saltzberg, S. Sarkar, J. Schmedtje, R. Schneider, G. Schuyler, J. Shanes, A. Sharma, C. Siegel, R. Siegel, D. Silber, V. Singh, N. Singh, J. Singh, J. Sklar, R. Small, A. Smith, E. Smith, E. Smith, D. Smull, R. Sotolongo, C. Staniloae, D. Stapleton, P. Steele, J. Stehlik, M. Stein, W. Tang, U. Thadani, G. Torre-Amoine, B. Trichon, C. Tsai, R. Tummala, A. Van Bakel, R. Vicari, N. Vijay, K. Vijayaraghavan, T. Vittorio, M. Vossler, L. Wagoner, D. Wallis, N. Ward, M. Widmer, J. Wight, C. Wilkins, C. Williams, G. Williams, M. Winchester, E. Winkel, B. Wittmer, D. Wood, D. Wormer, R. Wright, Z. Xu, M. Yasin, R. Zolty.</p></app></app-group><ref-list><title>References</title><ref id="HFS204C1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Meara</surname><given-names>E</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name></person-group><article-title>Anemia and heart failure</article-title><source>Curr Heart Fail Rep</source><year>2004</year><volume>1</volume><fpage>176</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">16036042</pub-id></element-citation></ref><ref id="HFS204C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>I</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Whitmore</surname><given-names>J</given-names></name><name><surname>Warren</surname><given-names>M</given-names></name><name><surname>Pham</surname><given-names>A</given-names></name><name><surname>McCamish</surname><given-names>MA</given-names></name><name><surname>Burton</surname><given-names>PB</given-names></name></person-group><article-title>Anemia and its relationship to clinical outcome in heart failure</article-title><source>Circulation</source><year>2004</year><volume>110</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">15210591</pub-id></element-citation></ref><ref id="HFS204C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggioni</surname><given-names>AP</given-names></name><name><surname>Opasich</surname><given-names>C</given-names></name><name><surname>Anand</surname><given-names>I</given-names></name><name><surname>Barlera</surname><given-names>S</given-names></name><name><surname>Carbonieri</surname><given-names>E</given-names></name><name><surname>Gonzini</surname><given-names>L</given-names></name><name><surname>Tavazzi</surname><given-names>L</given-names></name><name><surname>Latini</surname><given-names>R</given-names></name><name><surname>Cohn</surname><given-names>J</given-names></name></person-group><article-title>Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice</article-title><source>J Card Fail</source><year>2005</year><volume>11</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">15732027</pub-id></element-citation></ref><ref id="HFS204C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>Kuskowski</surname><given-names>MA</given-names></name><name><surname>Rector</surname><given-names>TS</given-names></name><name><surname>Florea</surname><given-names>VG</given-names></name><name><surname>Glazer</surname><given-names>RD</given-names></name><name><surname>Hester</surname><given-names>A</given-names></name><name><surname>Chiang</surname><given-names>YT</given-names></name><name><surname>Aknay</surname><given-names>N</given-names></name><name><surname>Maggioni</surname><given-names>AP</given-names></name><name><surname>Opasich</surname><given-names>C</given-names></name><name><surname>Latini</surname><given-names>R</given-names></name><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group><article-title>Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT</article-title><source>Circulation</source><year>2005</year><volume>112</volume><fpage>1121</fpage><lpage>1127</lpage><pub-id pub-id-type="pmid">16103233</pub-id></element-citation></ref><ref id="HFS204C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Meara</surname><given-names>E</given-names></name><name><surname>Clayton</surname><given-names>T</given-names></name><name><surname>McEntegart</surname><given-names>MB</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Lang</surname><given-names>CC</given-names></name><name><surname>Roger</surname><given-names>SD</given-names></name><name><surname>Young</surname><given-names>JB</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Granger</surname><given-names>CB</given-names></name><name><surname>Ostergren</surname><given-names>J</given-names></name><name><surname>Olofsson</surname><given-names>B</given-names></name><name><surname>Michelson</surname><given-names>EL</given-names></name><name><surname>Pocock</surname><given-names>S</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name></person-group><collab>CHARM. Committees and Investigators</collab><article-title>Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure:results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>986</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">16476847</pub-id></element-citation></ref><ref id="HFS204C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Charlesworth</surname><given-names>A</given-names></name><name><surname>Okonko</surname><given-names>D</given-names></name><name><surname>Metra</surname><given-names>M</given-names></name><name><surname>Di Lenarda</surname><given-names>A</given-names></name><name><surname>Remme</surname><given-names>W</given-names></name><name><surname>Moullet</surname><given-names>C</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name></person-group><article-title>The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET</article-title><source>Eur Heart J</source><year>2006</year><volume>27</volume><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">16717081</pub-id></element-citation></ref><ref id="HFS204C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenveld</surname><given-names>HF</given-names></name><name><surname>Januzzi</surname><given-names>JL</given-names></name><name><surname>Damman</surname><given-names>K</given-names></name><name><surname>van Wijngaarden</surname><given-names>J</given-names></name><name><surname>Hillege</surname><given-names>HL</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>van der Meer</surname><given-names>P</given-names></name></person-group><article-title>Anemia and mortality in heart failure patients a systematic review and meta-analysis</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>52</volume><fpage>818</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">18755344</pub-id></element-citation></ref><ref id="HFS204C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KF</given-names><suffix>Jr</suffix></name><name><surname>Patterson</surname><given-names>JH</given-names></name><name><surname>Oren</surname><given-names>RM</given-names></name><name><surname>Mehra</surname><given-names>MR</given-names></name><name><surname>O'Connor</surname><given-names>CM</given-names></name><name><surname>Pi&#x000f1;a</surname><given-names>IL</given-names></name><name><surname>Miller</surname><given-names>AB</given-names></name><name><surname>Chiong</surname><given-names>JR</given-names></name><name><surname>Dunlap</surname><given-names>SH</given-names></name><name><surname>Cotts</surname><given-names>WG</given-names></name><name><surname>Felker</surname><given-names>GM</given-names></name><name><surname>Schocken</surname><given-names>DD</given-names></name><name><surname>Schwartz</surname><given-names>TA</given-names></name><name><surname>Ghali</surname><given-names>JK</given-names></name></person-group><collab>STAMINA-HFP. Registry Investigators</collab><article-title>Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry</article-title><source>Am Heart J</source><year>2009</year><volume>157</volume><fpage>926</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">19376323</pub-id></element-citation></ref><ref id="HFS204C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westenbrink</surname><given-names>BD</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name></person-group><article-title>Anemia in chronic heart failure: etiology and treatment options</article-title><source>Curr Opin Cardiol</source><year>2008</year><volume>23</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">18303527</pub-id></element-citation></ref><ref id="HFS204C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>IS</given-names></name></person-group><article-title>Pathophysiology of anemia in heart failure</article-title><source>Heart Fail Clin</source><year>2010</year><volume>6</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">20630402</pub-id></element-citation></ref><ref id="HFS204C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westenbrink</surname><given-names>BD</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>Schuringa</surname><given-names>JJ</given-names></name><name><surname>Klinkenberg</surname><given-names>T</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Vellenga</surname><given-names>E</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name></person-group><article-title>Bone marrow dysfunction in chronic heart failure patients</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><fpage>676</fpage><lpage>684</lpage><pub-id pub-id-type="pmid">20427614</pub-id></element-citation></ref><ref id="HFS204C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Macdougall</surname><given-names>IC</given-names></name></person-group><article-title>Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches</article-title><source>Nat Rev Cardiol</source><year>2011</year><volume>8</volume><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">21629210</pub-id></element-citation></ref><ref id="HFS204C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwich</surname><given-names>TB</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Hamilton</surname><given-names>MA</given-names></name><name><surname>MacLellan</surname><given-names>WR</given-names></name><name><surname>Borenstein</surname><given-names>J</given-names></name></person-group><article-title>Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure</article-title><source>J Am Coll Cardiol</source><year>2002</year><volume>39</volume><fpage>1780</fpage><lpage>1786</lpage><pub-id pub-id-type="pmid">12039491</pub-id></element-citation></ref><ref id="HFS204C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>K</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Gaston-Johansson</surname><given-names>F</given-names></name><name><surname>Ekman</surname><given-names>I</given-names></name></person-group><article-title>Fatigue and anaemia in patients with chronic heart failure</article-title><source>Eur J Heart Fail</source><year>2006</year><volume>8</volume><fpage>744</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">16690352</pub-id></element-citation></ref><ref id="HFS204C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felker</surname><given-names>GM</given-names></name><name><surname>Adams</surname><given-names>KF</given-names><suffix>Jr</suffix></name><name><surname>Gattis</surname><given-names>WA</given-names></name><name><surname>O'Connor</surname><given-names>CM</given-names></name></person-group><article-title>Anemia as a risk factor and therapeutic target in heart failure</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>959</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">15337204</pub-id></element-citation></ref><ref id="HFS204C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>IS</given-names></name></person-group><article-title>Anemia and chronic heart failure implications and treatment options</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>52</volume><fpage>501</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">18687241</pub-id></element-citation></ref><ref id="HFS204C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>K</given-names></name><name><surname>Kotecha</surname><given-names>D</given-names></name><name><surname>Walters</surname><given-names>JA</given-names></name><name><surname>Manzano</surname><given-names>L</given-names></name><name><surname>Palazzuoli</surname><given-names>A</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Flather</surname><given-names>M</given-names></name></person-group><article-title>Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients</article-title><source>Cochrane Database Syst Rev</source><year>2010</year><volume>1</volume><fpage>CD007613</fpage><pub-id pub-id-type="pmid">20091643</pub-id></element-citation></ref><ref id="HFS204C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Sullivan</surname><given-names>JT</given-names></name><name><surname>Ball</surname><given-names>S</given-names></name><name><surname>Horowitz</surname><given-names>JD</given-names></name><name><surname>Agoram</surname><given-names>B</given-names></name><name><surname>Rosser</surname><given-names>D</given-names></name><name><surname>Yates</surname><given-names>W</given-names></name><name><surname>Tin</surname><given-names>L</given-names></name><name><surname>Fuentealba</surname><given-names>P</given-names></name><name><surname>Burton</surname><given-names>PB</given-names></name></person-group><article-title>Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation</article-title><source>J Cardiovasc Pharmacol</source><year>2005</year><volume>46</volume><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">16044026</pub-id></element-citation></ref><ref id="HFS204C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Szachniewicz</surname><given-names>J</given-names></name><name><surname>Okonko</surname><given-names>D</given-names></name><name><surname>Ledwidge</surname><given-names>M</given-names></name><name><surname>Zymlinski</surname><given-names>R</given-names></name><name><surname>Ryan</surname><given-names>E</given-names></name><name><surname>Wasserman</surname><given-names>SM</given-names></name><name><surname>Baker</surname><given-names>N</given-names></name><name><surname>Rosser</surname><given-names>D</given-names></name><name><surname>Rosen</surname><given-names>SD</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><name><surname>Banasiak</surname><given-names>W</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>McDonald</surname><given-names>K</given-names></name></person-group><article-title>Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>49</volume><fpage>753</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">17306703</pub-id></element-citation></ref><ref id="HFS204C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><name><surname>Cohen-Solal</surname><given-names>A</given-names></name><name><surname>Lok</surname><given-names>DJ</given-names></name><name><surname>Wasserman</surname><given-names>SM</given-names></name><name><surname>Baker</surname><given-names>N</given-names></name><name><surname>Rosser</surname><given-names>D</given-names></name><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name></person-group><article-title>Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia</article-title><source>Eur Heart J</source><year>2007</year><volume>28</volume><fpage>2208</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">17681958</pub-id></element-citation></ref><ref id="HFS204C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghali</surname><given-names>JK</given-names></name><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>Abraham</surname><given-names>WT</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Greenberg</surname><given-names>B</given-names></name><name><surname>Krum</surname><given-names>H</given-names></name><name><surname>Massie</surname><given-names>BM</given-names></name><name><surname>Wasserman</surname><given-names>SM</given-names></name><name><surname>Trotman</surname><given-names>ML</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Knusel</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>P</given-names></name></person-group><collab>Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group</collab><article-title>Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia</article-title><source>Circulation</source><year>2008</year><volume>117</volume><fpage>526</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">18195176</pub-id></element-citation></ref><ref id="HFS204C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapholz</surname><given-names>M</given-names></name><name><surname>Abraham</surname><given-names>WT</given-names></name><name><surname>Ghali</surname><given-names>JK</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Knusel</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wasserman</surname><given-names>SM</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name></person-group><article-title>The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure</article-title><source>Eur J Heart Fail</source><year>2009</year><volume>11</volume><fpage>1071</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">19815661</pub-id></element-citation></ref><ref id="HFS204C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsic</surname><given-names>E</given-names></name><name><surname>Westenbrink</surname><given-names>BD</given-names></name><name><surname>van der Meer</surname><given-names>P</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Schoemaker</surname><given-names>RG</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name></person-group><article-title>Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit</article-title><source>Eur J Heart Fail</source><year>2008</year><volume>10</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">18077209</pub-id></element-citation></ref><ref id="HFS204C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Meer</surname><given-names>P</given-names></name><name><surname>Lipsic</surname><given-names>E</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name></person-group><article-title>Asialoerythropoietin to protect the failing heart: is it possible to run with the hare and hunt with the hounds?</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>56</volume><fpage>1959</fpage><lpage>1960</lpage><pub-id pub-id-type="pmid">21109121</pub-id></element-citation></ref><ref id="HFS204C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleijn</surname><given-names>L</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name></person-group><article-title>Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><fpage>215</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">20156936</pub-id></element-citation></ref><ref id="HFS204C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Szczech</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>KL</given-names></name><name><surname>Barnhart</surname><given-names>H</given-names></name><name><surname>Sapp</surname><given-names>S</given-names></name><name><surname>Wolfson</surname><given-names>M</given-names></name><name><surname>Reddan</surname><given-names>D</given-names></name></person-group><collab>CHOIR Investigators</collab><article-title>Correction of anemia with epoetin alfa in chronic kidney disease</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>2085</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17108343</pub-id></element-citation></ref><ref id="HFS204C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000fc;eke</surname><given-names>TB</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Clyne</surname><given-names>N</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name><name><surname>Macdougall</surname><given-names>IC</given-names></name><name><surname>Tsakiris</surname><given-names>D</given-names></name><name><surname>Burger</surname><given-names>HU</given-names></name><name><surname>Scherhag</surname><given-names>A</given-names></name></person-group><collab>CREATE Investigators</collab><article-title>Normalization of hemoglobin level in patients with chronic kidney disease and anemia</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>2071</fpage><lpage>2084</lpage><pub-id pub-id-type="pmid">17108342</pub-id></element-citation></ref><ref id="HFS204C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Burdmann</surname><given-names>EA</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>de Zeeuw</surname><given-names>D</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name><name><surname>Feyzi</surname><given-names>JM</given-names></name><name><surname>Ivanovich</surname><given-names>P</given-names></name><name><surname>Kewalramani</surname><given-names>R</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Lewis</surname><given-names>EF</given-names></name><name><surname>McGill</surname><given-names>JB</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Parfrey</surname><given-names>P</given-names></name><name><surname>Parving</surname><given-names>HH</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Toto</surname><given-names>R</given-names></name></person-group><collab>TREAT Investigators</collab><article-title>A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>2019</fpage><lpage>2032</lpage><pub-id pub-id-type="pmid">19880844</pub-id></element-citation></ref><ref id="HFS204C29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>E</given-names></name><name><surname>Solomon</surname><given-names>S</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Pfeffer</surname><given-names>M</given-names></name></person-group><article-title>Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure:an updated, post-TREAT meta-analysis</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><fpage>936</fpage><lpage>942</lpage><pub-id pub-id-type="pmid">20525985</pub-id></element-citation></ref><ref id="HFS204C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>Diaz</surname><given-names>R</given-names></name><name><surname>Maggioni</surname><given-names>AP</given-names></name><name><surname>O'Connor</surname><given-names>C</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Polu</surname><given-names>KR</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Tendera</surname><given-names>M</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Wasserman</surname><given-names>SM</given-names></name><name><surname>Young</surname><given-names>JB</given-names></name></person-group><collab>RED-HF Committees and Investigators</collab><article-title>Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity&#x02013;mortality trial</article-title><source>Eur J Heart Fail</source><year>2009</year><volume>11</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">19633103</pub-id></element-citation></ref><ref id="HFS204C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name></person-group><collab>RED-HF Executive Committee</collab><article-title>Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial</article-title><source>Eur J Heart Fail</source><year>2007</year><volume>9</volume><fpage>110</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">17270493</pub-id></element-citation></ref><ref id="HFS204C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>CP</given-names></name><name><surname>Porter</surname><given-names>CB</given-names></name><name><surname>Bresnahan</surname><given-names>DR</given-names></name><name><surname>Spertus</surname><given-names>JA</given-names></name></person-group><article-title>Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure</article-title><source>J Am Coll Cardiol</source><year>2000</year><volume>35</volume><fpage>1245</fpage><lpage>1255</lpage><pub-id pub-id-type="pmid">10758967</pub-id></element-citation></ref><ref id="HFS204C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannad</surname><given-names>F</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Krum</surname><given-names>H</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Vincent</surname><given-names>J</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Pitt</surname><given-names>B</given-names></name></person-group><collab>EMPHASIS-HF Study Group</collab><article-title>Eplerenone in patients with systolic heart failure and mild symptoms</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">21073363</pub-id></element-citation></ref><ref id="HFS204C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Dubost-Brama</surname><given-names>A</given-names></name><name><surname>Lerebours</surname><given-names>G</given-names></name><name><surname>Tavazzi</surname><given-names>L</given-names></name></person-group><collab>SHIFT Investigators</collab><article-title>Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study</article-title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>875</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">20801500</pub-id></element-citation></ref><ref id="HFS204C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>AS</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Talajic</surname><given-names>M</given-names></name><name><surname>Arnold</surname><given-names>MO</given-names></name><name><surname>Sheldon</surname><given-names>R</given-names></name><name><surname>Connolly</surname><given-names>S</given-names></name><name><surname>Hohnloser</surname><given-names>SH</given-names></name><name><surname>Nichol</surname><given-names>G</given-names></name><name><surname>Birnie</surname><given-names>DH</given-names></name><name><surname>Sapp</surname><given-names>JL</given-names></name><name><surname>Yee</surname><given-names>R</given-names></name><name><surname>Healey</surname><given-names>JS</given-names></name><name><surname>Rouleau</surname><given-names>JL</given-names></name></person-group><collab>Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators</collab><article-title>Cardiac-resynchronization therapy for mild-to-moderate heart failure</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>2385</fpage><lpage>2395</lpage><pub-id pub-id-type="pmid">21073365</pub-id></element-citation></ref><ref id="HFS204C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstam</surname><given-names>MA</given-names></name><name><surname>Neaton</surname><given-names>JD</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>FA</given-names></name><name><surname>Riegger</surname><given-names>GA</given-names></name><name><surname>Malbecq</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>RD</given-names></name><name><surname>Guptha</surname><given-names>S</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name></person-group><collab>HEAAL Investigators</collab><article-title>Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial</article-title><source>Lancet</source><year>2009</year><volume>374</volume><fpage>1840</fpage><lpage>1848</lpage><pub-id pub-id-type="pmid">19922995</pub-id></element-citation></ref><ref id="HFS204C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Daubert</surname><given-names>JC</given-names></name><name><surname>Erdmann</surname><given-names>E</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Gras</surname><given-names>D</given-names></name><name><surname>Kappenberger</surname><given-names>L</given-names></name><name><surname>Klein</surname><given-names>W</given-names></name><name><surname>Tavazzi</surname><given-names>L</given-names></name></person-group><collab>CARE-HF study Steering Committee and Investigators</collab><article-title>Baseline characteristics of patients recruited into the CARE-HF study</article-title><source>Eur J Heart Fail</source><year>2005</year><volume>7</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">15701468</pub-id></element-citation></ref><ref id="HFS204C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Di Lenarda</surname><given-names>A</given-names></name><name><surname>Hanrath</surname><given-names>P</given-names></name><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>Lubsen</surname><given-names>J</given-names></name><name><surname>Lutiger</surname><given-names>B</given-names></name><name><surname>Metra</surname><given-names>M</given-names></name><name><surname>Remme</surname><given-names>WJ</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Scherhag</surname><given-names>A</given-names></name><name><surname>Skene</surname><given-names>A</given-names></name></person-group><collab>Carvedilol Or Metoprolol European Trial Investigators</collab><article-title>Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">12853193</pub-id></element-citation></ref><ref id="HFS204C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjalmarson</surname><given-names>A</given-names></name><name><surname>Goldstein</surname><given-names>S</given-names></name><name><surname>Fagerberg</surname><given-names>B</given-names></name><name><surname>Wedel</surname><given-names>H</given-names></name><name><surname>Waagstein</surname><given-names>F</given-names></name><name><surname>Kjekshus</surname><given-names>J</given-names></name><name><surname>Wikstrand</surname><given-names>J</given-names></name><name><surname>El Allaf</surname><given-names>D</given-names></name><name><surname>V&#x000ed;tovec</surname><given-names>J</given-names></name><name><surname>Aldershvile</surname><given-names>J</given-names></name><name><surname>Halinen</surname><given-names>M</given-names></name><name><surname>Dietz</surname><given-names>R</given-names></name><name><surname>Neuhaus</surname><given-names>KL</given-names></name><name><surname>J&#x000e1;nosi</surname><given-names>A</given-names></name><name><surname>Thorgeirsson</surname><given-names>G</given-names></name><name><surname>Dunselman</surname><given-names>PH</given-names></name><name><surname>Gullestad</surname><given-names>L</given-names></name><name><surname>Kuch</surname><given-names>J</given-names></name><name><surname>Herlitz</surname><given-names>J</given-names></name><name><surname>Rickenbacher</surname><given-names>P</given-names></name><name><surname>Ball</surname><given-names>S</given-names></name><name><surname>Gottlieb</surname><given-names>S</given-names></name><name><surname>Deedwania</surname><given-names>P</given-names></name></person-group><collab>MERIT-HF Study Group</collab><article-title>Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL. Randomized Intervention Trial in congestive heart failure (MERIT-HF)</article-title><source>JAMA</source><year>2000</year><volume>283</volume><fpage>1295</fpage><lpage>1302</lpage><pub-id pub-id-type="pmid">10714728</pub-id></element-citation></ref><ref id="HFS204C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>J</given-names></name><name><surname>Ostergren</surname><given-names>J</given-names></name><name><surname>Pfeffer</surname><given-names>M</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Granger</surname><given-names>C</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Held</surname><given-names>P</given-names></name><name><surname>Michelson</surname><given-names>E</given-names></name><name><surname>Olofsson</surname><given-names>B</given-names></name></person-group><collab>CHARM committees, investigators</collab><article-title>Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme</article-title><source>Eur J Heart Fail</source><year>2003</year><volume>5</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">12798823</pub-id></element-citation></ref><ref id="HFS204C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>KE</given-names></name><name><surname>Pi&#x000f1;a</surname><given-names>IL</given-names></name><name><surname>Whellan</surname><given-names>DJ</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Blumenthal</surname><given-names>JA</given-names></name><name><surname>Ellis</surname><given-names>SJ</given-names></name><name><surname>Fine</surname><given-names>LJ</given-names></name><name><surname>Howlett</surname><given-names>JG</given-names></name><name><surname>Keteyian</surname><given-names>SJ</given-names></name><name><surname>Kitzman</surname><given-names>DW</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Miller</surname><given-names>NH</given-names></name><name><surname>Schulman</surname><given-names>KA</given-names></name><name><surname>Spertus</surname><given-names>JA</given-names></name><name><surname>O'Connor</surname><given-names>CM</given-names></name><name><surname>Weinfurt</surname><given-names>KP</given-names></name></person-group><collab>HF-ACTION Investigators</collab><article-title>Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial</article-title><source>JAMA</source><year>2009</year><volume>301</volume><fpage>1451</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">19351942</pub-id></element-citation></ref><ref id="HFS204C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Hall</surname><given-names>WJ</given-names></name><name><surname>Cannom</surname><given-names>DS</given-names></name><name><surname>Klein</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>MW</given-names></name><name><surname>Daubert</surname><given-names>JP</given-names></name><name><surname>Estes</surname><given-names>NA</given-names><suffix>3rd</suffix></name><name><surname>Foster</surname><given-names>E</given-names></name><name><surname>Greenberg</surname><given-names>H</given-names></name><name><surname>Higgins</surname><given-names>SL</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Wilber</surname><given-names>D</given-names></name><name><surname>Zareba</surname><given-names>W</given-names></name></person-group><collab>MADIT-CRT Trial Investigators</collab><article-title>Cardiac-resynchronization therapy for the prevention of heart-failure events</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>1329</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">19723701</pub-id></element-citation></ref><ref id="HFS204C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velazquez</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Deja</surname><given-names>MA</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Sopko</surname><given-names>G</given-names></name><name><surname>Marchenko</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>IS</given-names></name><name><surname>Pohost</surname><given-names>G</given-names></name><name><surname>Gradinac</surname><given-names>S</given-names></name><name><surname>Abraham</surname><given-names>WT</given-names></name><name><surname>Yii</surname><given-names>M</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Szwed</surname><given-names>H</given-names></name><name><surname>Ferrazzi</surname><given-names>P</given-names></name><name><surname>Petrie</surname><given-names>MC</given-names></name><name><surname>O'Connor</surname><given-names>CM</given-names></name><name><surname>Panchavinnin</surname><given-names>P</given-names></name><name><surname>She</surname><given-names>L</given-names></name><name><surname>Bonow</surname><given-names>RO</given-names></name><name><surname>Rankin</surname><given-names>GR</given-names></name><name><surname>Jones</surname><given-names>RH</given-names></name><name><surname>Rouleau</surname><given-names>JL</given-names></name></person-group><collab>STICH Investigators</collab><article-title>Coronary-artery bypass surgery in patients with left ventricular dysfunction</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1607</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">21463150</pub-id></element-citation></ref><ref id="HFS204C44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slaughter</surname><given-names>MS</given-names></name><name><surname>Rogers</surname><given-names>JG</given-names></name><name><surname>Milano</surname><given-names>CA</given-names></name><name><surname>Russell</surname><given-names>SD</given-names></name><name><surname>Conte</surname><given-names>JV</given-names></name><name><surname>Feldman</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Tatooles</surname><given-names>AJ</given-names></name><name><surname>Delgado</surname><given-names>RM</given-names><suffix>3rd</suffix></name><name><surname>Long</surname><given-names>JW</given-names></name><name><surname>Wozniak</surname><given-names>TC</given-names></name><name><surname>Ghumman</surname><given-names>W</given-names></name><name><surname>Farrar</surname><given-names>DJ</given-names></name><name><surname>Frazier</surname><given-names>OH</given-names></name></person-group><collab>HeartMate II Investigators</collab><article-title>Advanced heart failure treated with continuous-flow left ventricular assist device</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>2241</fpage><lpage>2251</lpage><pub-id pub-id-type="pmid">19920051</pub-id></element-citation></ref><ref id="HFS204C45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjekshus</surname><given-names>J</given-names></name><name><surname>Apetrei</surname><given-names>E</given-names></name><name><surname>Barrios</surname><given-names>V</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Cleland</surname><given-names>JG</given-names></name><name><surname>Cornel</surname><given-names>JH</given-names></name><name><surname>Dunselman</surname><given-names>P</given-names></name><name><surname>Fonseca</surname><given-names>C</given-names></name><name><surname>Goudev</surname><given-names>A</given-names></name><name><surname>Grande</surname><given-names>P</given-names></name><name><surname>Gullestad</surname><given-names>L</given-names></name><name><surname>Hjalmarson</surname><given-names>A</given-names></name><name><surname>Hradec</surname><given-names>J</given-names></name><name><surname>J&#x000e1;nosi</surname><given-names>A</given-names></name><name><surname>Kamensk&#x000fd;</surname><given-names>G</given-names></name><name><surname>Komajda</surname><given-names>M</given-names></name><name><surname>Korewicki</surname><given-names>J</given-names></name><name><surname>Kuusi</surname><given-names>T</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Mareev</surname><given-names>V</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Ranjith</surname><given-names>N</given-names></name><name><surname>Schaufelberger</surname><given-names>M</given-names></name><name><surname>Vanhaecke</surname><given-names>J</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Waagstein</surname><given-names>F</given-names></name><name><surname>Wedel</surname><given-names>H</given-names></name><name><surname>Wikstrand</surname><given-names>J</given-names></name></person-group><collab>CORONA Group</collab><article-title>Rosuvastatin in older patients with systolic heart failure</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>2248</fpage><lpage>2261</lpage><pub-id pub-id-type="pmid">17984166</pub-id></element-citation></ref><ref id="HFS204C46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Comin Colet</surname><given-names>J</given-names></name><name><surname>Filippatos</surname><given-names>G</given-names></name><name><surname>Willenheimer</surname><given-names>R</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name><name><surname>L&#x000fc;scher</surname><given-names>TF</given-names></name><name><surname>Bart</surname><given-names>B</given-names></name><name><surname>Banasiak</surname><given-names>W</given-names></name><name><surname>Niegowska</surname><given-names>J</given-names></name><name><surname>Kirwan</surname><given-names>BA</given-names></name><name><surname>Mori</surname><given-names>C</given-names></name><name><surname>von Eisenhart Rothe</surname><given-names>B</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name></person-group><collab>FAIR-HF Trial Investigators</collab><article-title>Ferric carboxymaltose in patients with heart failure and iron deficiency</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>2436</fpage><lpage>2448</lpage><pub-id pub-id-type="pmid">19920054</pub-id></element-citation></ref></ref-list></back></article>